Collagen accumulation in osteosarcoma cells lacking GLT25D1 collagen galactosyltransferase by Baumann, Stephan & Hennet, Thierry
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2016
Collagen accumulation in osteosarcoma cells lacking GLT25D1 collagen
galactosyltransferase
Baumann, Stephan; Hennet, Thierry
Abstract: Collagen is post-translationally modified by prolyl and lysyl hydroxylation and subsequently by
glycosylation of hydroxylysine. Despite the widespread occurrence of the glycan structure Glc(￿1-2)Gal
linked to hydroxylysine in animals, the functional significance of collagen glycosylation remains elusive. To
address the role of glycosylation in collagen expression, folding, and secretion, we used the CRISPR/Cas9
system to inactivate the collagen galactosyltransferase GLT25D1 and GLT25D2 genes in osteosarcoma
cells. Loss of GLT25D1 led to increased expression and intracellular accumulation of collagen type I,
whereas loss of GLT25D2 had no effect on collagen secretion. Inactivation of the GLT25D1 gene resulted
in a compensatory induction of GLT25D2 expression. Loss of GLT25D1 decreased collagen glycosylation
by up to 60% but did not alter collagen folding and thermal stability. Whereas cells harboring individually
inactivated GLT25D1 and GLT25D2 genes could be recovered and maintained in culture, cell clones with
simultaneously inactive GLT25D1 and GLT25D2 genes could be not grown and studied, suggesting that
a complete loss of collagen glycosylation impairs osteosarcoma cell proliferation and viability.
DOI: 10.1074/jbc.M116.723379
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-130488
Accepted Version
Originally published at:
Baumann, Stephan; Hennet, Thierry (2016). Collagen accumulation in osteosarcoma cells lacking GLT25D1
collagen galactosyltransferase. Journal of Biological Chemistry, 291(35):18514-18524. DOI: 10.1074/jbc.M116.723379
Accumulation of collagen caused by depleted glycosylation 
1 
 
Collagen Accumulation in Osteosarcoma Cells lacking GLT25D1 Collagen Galactosyltransfer-
ase  
Stephan Baumann, Thierry Hennet* 
From the Institute of Physiology, University of Zurich, Zurich, Switzerland  
Running Title: Accumulation of collagen caused by depleted glycosylation 
* Correspondence to: Thierry Hennet, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, 
Switzerland, Tel. +41 44 635 50 80, thierry.hennet@uzh.ch  
Key Words: Collagen, glycosylation, CRISPR/Cas, osteosarcoma, cellular regulation 
 
Abstract 
Collagen is post-translationally modified by 
prolyl and lysyl hydroxylation and subsequently 
by glycosylation of hydroxylysine. Despite the 
widespread occurrence of the glycan structure 
Glc(1-2)Gal linked to hydroxylysine in animals, 
the functional significance of collagen glycosyla-
tion remains elusive. To address the role glyco-
sylation in collagen expression, folding and secre-
tion, we used the CRISPR/ Cas9 system to inacti-
vate the collagen galactosyltransferase GLT25D1 
and GLT25D2 genes in osteosarcoma cells. Loss 
of GLT25D1 lead to increased expression and in-
tracellular accumulation of collagen type I 
whereas loss of GLT25D2 had no effect on colla-
gen secretion. Inactivation of the GLT25D1 gene 
resulted in a compensatory induction of 
GLT25D2 expression. Loss of GLT25D1 de-
creased collagen glycosylation by up to 60% but 
did not alter collagen folding and thermal stabil-
ity. Whereas cells harboring individually inacti-
vated GLT25D1 and GLT25D2 genes could be re-
covered and maintained in culture, cell clone with 
simultaneously inactive GLT25D1 and GLT25D2 
genes could be not grown and studied, suggesting 
that a complete loss of collagen glycosylation im-
pairs osteosarcoma cell proliferation and viabil-
ity. 
Introduction 
Collagens, the most abundant animal proteins, are 
essential components of the extracellular matrix 
of various tissues and organs. Collagens are 
mainly located in connective tissue and regulate a 
variety of biological processes such as cell attach-
ment, migration, proliferation, and differentiation 
(1). Collagens feature specific domains composed 
of Gly-X-Y repeats with proline and lysine often 
occupying the X and Y positions. Nascent procol-
lagen chains are modified co-translationally by 
prolyl 4-hydroxylation (2), prolyl 3-hydroxyla-
tion (3), lysyl hydroxylation (4), and by glycosy-
lation of selected hydroxylysine (Hyl) residues 
(5). Collagen modifications take place in the en-
doplasmic reticulum before completion of triple 
helix assembly (6). The importance of collagen 
hydroxylation is underlined by various diseases 
linked to defective collagen modifications. For 
example, prolyl 3-hydroxylase 1 deficiency 
causes osteogenesis imperfecta with severe 
skeletal deformation (7), mutation in the lysyl 
hydroxylase 1 PLOD1 gene causes Ehlers-Danlos 
syndrome type VI (8). Mutations in the lysyl 
hydroxylase 2 PLOD2 gene cause Bruck 
syndrome (9) and mutations in the lysyl 
hydroxylase 3 PLOD3 gene cause connective 
tissue defects typical of collagen disorders (10). 
A recently identified mutation of the prolyl 4-
hydroxylase β-subunit protein disulfide 
isomerase causes Cole-Carpenter syndrome (11). 
By contrast, the biological significance of 
collagen glycosylation remains elusive as no 
disease has been associated with the process and 
no model organism harboring defective collagen 
glycosylation has been described to date.   
The GLT25D1 and GLT25D2 genes encode Hyl-
specific galactosyltransferase enzymes, which in-
itiate collagen glycosylation (12,13). The gene 
encoding the 1-2 glucosyltransferase enzyme, 
which adds glucose (Glc) to galactose (Gal), has 
not been identified yet, although the lysyl hydrox-
ylase 3 enzyme has been claimed to also act as a 
collagen glucosyltransferase (14).The resulting 
Glc(1-2)Gal disaccharide is strongly conserved 
in all animal collagens, from sponges up to mam-
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mals (14-17). Whereas GLT25D1 is broadly ex-
pressed across tissues, GLT25D2 is mainly ex-
pressed in brain tissue and at low levels in skeletal 
muscle (18). The GLT25D1 and GLT25D2 galac-
tosyltransferases share identical enzymatic activ-
ities and substrate specificities, as they are able to 
glycosylate various types of collagen to similar 
levels (18). 
Despite the recent identification of the GLT25D1 
and GLT25D2 galactosyltransferases, little is 
known about the functional role of collagen gly-
cosylation. Glycosylation has been shown to af-
fect the binding of  the urokinase-type plasmino-
gen activator receptor associated protein 
(uPARAP) to collagen type IV, thereby implying 
collagen glycosylation in receptor mediated ma-
trix remodeling (19). Also integrins appear to be 
sensitive to collagen glycosylation, as decreased 
integrin-mediated cell adhesion was measured on 
galactosylated collagen peptides compared with 
unmodified peptides (20,21). Glycosylation of 
Hyl is notably not confined to collagens. The col-
lagen domains of multimeric proteins such as ad-
iponectin and mannose-binding lectin also carry 
glycosylated Hyl, where lysyl hydroxylation and 
glycosylation influence protein oligomerization 
(22-24).  
Considering the possible functional involvement 
of glycosylation in collagen folding and intracel-
lular trafficking, we investigated collagen proper-
ties after inactivation of the GLT25D1 and 
GLT25D2 galactosyltransferase genes in osteo-
sarcoma cells, which produce large amounts of fi-
brillar collagens, including collagen type I, V and 
minor amounts of collagen type III.   
Results 
GLT25D1 and GLT25D2 inactivation in osteo-
sarcoma cells 
Collagen glycosylation is initiated by the transfer 
of Gal to Hyl catalyzed by GLT25D1 and 
GLT25D2 galactosyltransferase enzymes. To 
identify osteosarcoma cell lines generating high 
amounts of collagen galactosylation, we first an-
alyzed GLT25D1 and GLT25D2 gene expression 
in the three collagen producing osteosarcoma cell 
lines SaOS-2, MG63 and U2OS (25). As ex-
pected, GLT25D1 was the main collagen galacto-
syltransferase isoform expressed in osteosarcoma 
cells considering the restricted expression of 
GLT25D2 in brain and skeletal muscle (12). The 
transcript levels of GLT25D2 represented only 1 
to 4% of GLT25D1 levels in the three cell lines 
investigated (Fig. 1A). As a comparison, the 
PLOD3 gene encoding the lysyl hydroxylase 3 
enzyme was expressed between 0.5 to 2-fold the 
levels of GLT25D1 transcripts (Fig. 1A). The 
three collagen-modifying genes were expressed at 
the highest levels in SaOS-2 cells. Considering 
the strong expression of collagen galactosyltrans-
ferases and lysyl hydroxylase 3 genes in SaOS-2 
cells, as well as the prominent production of col-
lagen type I and highly glycosylated collagen type 
V in these cells (26), we primarily investigated 
the role of collagen glycosylation in SaOS-2 cells.      
The GLT25D1 and GLT25D2 galactosyltransfer-
ase genes were inactivated in SaOS-2 cells using 
the CRISPR/Cas9 system (27). The exons 7 to 10 
of GLT25D1 and the exons 7 to 12 of GLT25D2 
encode the GT25 domain required for galactosyl-
transferase activity (Fig. 1B). We therefore tar-
geted exon 2 to disrupt GLT25D1 and exon 3 to 
disrupt GLT25D2. To control for annealing spec-
ificity, we used a gRNA sequence nearly identical 
to the GLT25D1-targeting gRNA by including a 
single base mismatch (Fig. 1C). We obtained 2 
cell clones with null mutations at the expected lo-
cation of GLT25D1 after screening 10 clones and 
1 clone out of 16 with a null mutation in 
GLT25D2. Sanger sequencing of the targeted 
GLT25D1 exon 2 revealed a homozygous muta-
tion in the first cell clone and compound hetero-
zygous mutations in the second cell clone. Se-
quencing of GLT25D2 exon 3 confirmed a homo-
zygous point mutation at the expected genomic 
location (Fig. 1C). The frame-shift mutations de-
tected in the GLT25D1 clones yielded truncated 
open reading frames that lack the catalytic GT25 
domain. To obtain cell clones containing both 
GLT25D1-null and GLT25D2-null genes, we 
transfected GLT25D1-null cells with the 
CRISPR/Cas9 construct targeting the GLT25D2 
exon 3, which was successfully applied to disrupt 
GLT25D2.  After screening 100 cell clones, we 
identified 14 clones carrying a single mutated 
GLT25D2 allele but none that carried GLT25D1 
and GLT25D2 genes inactivated on both alleles. 
SaOS-2 cells transfected with the mismatch con-
trol gRNA construct did not yield any genomic 
mutation in the GLT25D1 targeted region after 
screening 10 cell clones. These 10 cell clones 
were pooled and used as control cells in subse-
quent experiments. The loss of GLT25D1 protein 
expression in SaOS-2 cells bearing inactivating 
mutations was confirmed by Western blotting 
(Fig. 1D). Changes in GLT25D2 protein levels 
could not be assessed because GLT25D2 re-
mained undetectable by Western Blot analysis in 
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the three osteosarcoma cell lines tested. The inac-
tivation of the GLT25D1 gene yielded a strong 
decrease of collagen galactosyltransferase activ-
ity down to 3-7% of the reference activity in na-
tive SaOS-2 cells and in the transfection control 
(Fig. 1E). Stable overexpression of a GLT25D1 
cDNA transgene in GLT25D1-null cells increased 
collagen galactosyltransferase by 6 to 8-fold. By 
contrast, the inactivation of GLT25D2 in SaOS-2 
cells only marginally decreased collagen galacto-
syltransferase activity to 92% of control values 
(Fig. 1E), thereby confirming GLT25D1 as the 
main enzyme mediating collagen galactosylation 
in SaOS-2. Taken together these data confirmed 
the successful functional inactivating role of the 
introduced mutations.  
GLT25D1 inactivation upregulates GLT25D2 
and COL1A1 mRNA levels  
GLT25D1 mRNA levels were significantly re-
duced in GLT25D1-null cells indicating induction 
of mRNA nonsense-mediated decay (28) (Fig. 
2A). GLT25D1 mRNA levels were increased by 
25% in GLT25D2-null cells, suggesting a possi-
ble compensatory effect by GLT25D1 upon inac-
tivation of GL525D2. This increase of GLT25D1 
transcript levels however did yield a correspond-
ing increase of collagen galactosyltransferase ac-
tivity as observed in figure 1E. Correspondingly, 
GLT25D2 was upregulated 3- to 5-fold in 
GLT25D1-null cells (Fig. 2B). Interestingly, 
GLT25D2 expression was also increased in 
GLT25D1-null cells overexpressing a GLT25D1 
cDNA transgene. As documented in a recent 
study, functional inactivation of single genes of-
ten results in compensatory overexpression by pa-
ralogous genes (29). Whereas GLT25D2 expres-
sion showed such a compensatory pattern, 
PLOD3 expression remained unchanged upon 
GLT25D1 and GLT25D2 inactivation (Fig. 2C), 
indicating that loss of collagen galactosyltransfer-
ase activity did not lead to increased lysyl hydrox-
ylase gene expression. Surprisingly, GLT25D1 
inactivation induced a strong expression of the 
COL1A1 gene encoding a collagen type I poly-
peptide (Fig. 2D). Normal COL1A1 expression 
was restored to control levels in GLT25D1-null 
cells upon overexpression of a GLT25D1 cDNA 
transgene, indicating that collagen galactosyl-
transferase activity was critical in regulating 
COL1A1 expression. Accordingly, COL1A1 
mRNA levels were normal in GLT25D2-null cells 
(Fig. 2D). The impact of collagen galactosyltrans-
ferase activity on collagen expression was spe-
cific to COL1A1 as COL5A1, encoding a collagen 
type V polypeptide, was insensitive to GLT25D1 
and GLT25D2 alterations (Fig. 2E).  
Collagen glycosylation in GLT25D1-null cells is 
partially restored by GLT25D2 
To quantify the compensatory effect of GLT25D2 
on collagen glycosylation in GLT25D1-null cells, 
we determined collagen post-translational modi-
fications in endogenously produced collagen by 
amino acid analysis. Whereas the overall levels of 
modified lysine remained unchanged, the amount 
of glycosylated Hyl carrying the Glc(1-2)Gal di-
saccharide decreased in GLT25D1-null cells by 
42 to 60% and the amounts of free Hyl increased 
correspondingly (Fig. 3A, B). Levels of free Hyl 
was correspondingly elevated in GLT25D1-null 
cells.  Alterations of collagen folding result in 
over-modification of collagen because of ex-
tended exposure of collagen substrates to prolyl 
hydroxylases in the endoplasmic reticulum (ER) 
compartment (30,31). Here, we did not detect any 
difference in hydroxyproline levels in GLT25D1-
null collagen compared with collagen from con-
trol cells, suggesting a normal rate of collagen 
folding in GLT25D1-null cells. 
Defects of triple helix formation because of al-
tered post-translational modifications of collagen 
often impair the trafficking of collagens (7,32). 
Under physiological conditions, only triple heli-
cal collagen is secreted, indicating that collagen 
secretion is directly proportional to triple helix 
formation (33).  We assessed the triple helical 
conformation of endogenous collagen in control 
and GLT25D1-null cells using circular dichroism. 
The ellipticity spectra showed the typical peak at 
222 nm as well as a minimum under 200 nm in 
both control and GLT25D1-null cells (Fig. 3C). 
Thermal stability was determined by monitoring 
changes in ellipticity at 222 nm during heating 
collagen from 30°C to 50°C. The heating curve 
consisted of two phases, possibly reflecting the 
mixed composition consisting of collagen type I 
and collagen type V. Both collagens extracted 
from GLT25D1-null and control cell lines exhib-
ited similar thermal properties with a normal 
melting temperature of 43.2°C (Fig. 3D). By con-
trast, denatured collagen derived from GLT25D1-
null cells refolded 40% faster than collagen from 
control cells (Fig. 3E). These results indicated 
that decreased collagen glycosylation affected the 
kinetic of triple helix formation but not triple he-
lix thermal stability. 
ER accumulation of collagen type I in GLT25D1-
null cells 
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To confirm the increased collagen type I produc-
tion in GLT25D1-null cells at the protein level, 
we first analyzed intracellular collagen amounts 
and distribution in control, GLT25D1- and 
GLT25D2-null SaOS-2 cells. In GLT25D1-null 
cells, collagen type I levels reached 150 to 190% 
of control values as measured by immunofluores-
cent channel intensity (Fig. 4A, B). Collagen type 
I levels normalized upon GLT25D1 cDNA over-
expression in GLT25D1-null cells. As noted for 
COL1A1 mRNA levels, inactivation of GLT25D2 
did not alter intracellular collagen type I amounts. 
The increased collagen type I levels detected by 
immunofluorescence were further confirmed by 
Western Blot analysis (Fig. 4C). Collagen expres-
sion in GLT25D2-inactivated cells was equal to 
control cells and to GLT25D1 cDNA-overex-
pressing GLT25D1-null cells (Fig. 4A), indicat-
ing a minor impact of GLT25D2 inactivation on 
collagen expression. 
Even though collagen type V contains 10 times 
more glycosylated Hyl residues than collagen 
type I (34), increased cellular amounts were only 
visible for collagen type I. Immunofluorescent 
staining for collagens type III and V remained un-
changed in GLT25D1-null cells (Fig. 5A). Inacti-
vation of GLT25D1 may only affect collagen type 
I levels because this type of collagen is by far pro-
duced at highest amounts in SaOS-2 cells. To lo-
cate the site of collagen accumulation, we colo-
calized collagen type I with the ER marker pro-
tein disulfide-isomerase (PDI). Elevated collagen 
type I levels were clearly associated with the ER 
compartment as shown by colocalization with 
PDI (Fig. 5B). Staining of SaOS-2 cells with the 
Golgi marker giantin showed a dilatation of Golgi 
stacks and co-localization with collagen type I, 
thus indicating the translocation of collagen type 
I from the ER to the Golgi (Fig. 5C). 
Increased collagen type I does not induce ER 
stress 
The intracellular accumulation of collagen type I 
and the occurrence of possibly improperly folded 
collagens could induce ER stress and thereby an 
unfolded protein response (35) in GLT25D1-null 
cells. To assess the possible induction of an un-
folded protein response, we measured splicing of 
XBP1 (Fig. 6A, B), the mRNA levels of GRP78 
(Fig. 6C) and ATF4 (Fig. 6D) as markers of the 
unfolded protein response. Tunicamycin was 
used as a positive control to induce the unfolded 
protein response (36). Whereas tunicamycin 
treatment induced a robust unfolded protein re-
sponse in control and GLT25D1-null cells, the 
three markers investigated remained unchanged 
in GLT25D1-null cells under conditions of colla-
gen type I ER accumulation (Fig. 6A-D). The ab-
sence of unfolded protein response in GLT25D1-
null cells indicated that the accumulation of col-
lagen type I was not related to impaired collagen 
folding in the ER and delayed transfer to the 
Golgi apparatus. As the accumulation of collagen 
type I could be related to delayed collagen secre-
tion, we quantified collagen production and secre-
tion. The main types of collagen secreted by 
SaOS-2 cells are collagen type I and the highly 
glycosylated collagen type V (25). Both control 
and GLT25D1-null cells produced and secreted 
these two typed of collagens normally as assessed 
by pulse-chase experiments (Fig. 7A,B). Even 
tough total collagen secretion was increased in 
GLT25D1-null cells, the rate of collagen degrada-
tion (Fig. 7C) and secretion (Fig. 7D) remained 
largely unaffected in GLT25D1-null cells. The 
amount of collagen secreted measured after 1 and 
2 h of chase was slightly higher in GLT25D1-null 
cells, but no difference was noticeable after 10 h, 
thus showing that loss of GLT25D1 maintained a 
normal rate collagen secretion. 
Discussion 
The inactivation of collagen galactosyltransferase 
GLT25D1 and GLT25D2 genes in osteosarcoma 
cells delineated the role of glycosylation in colla-
gen expression and intracellular trafficking. De-
fective glycosylation had no impact on the rate of 
collagen secretion and triple helix thermal stabil-
ity. By contrast, the loss of the main collagen ga-
lactosyltransferase isoform GLT25D1 led to ER 
accumulation of collagen type I in SaOS-2 cells. 
The intracellular accumulation of collagen type I 
resulted from increased collagen type I gene ex-
pression induced by low collagen galactosyltrans-
ferase activity. In addition, GLT25D1 inactivation 
was compensated at the transcriptional level by 
induction of GLT25D2, which is normally hardly 
expressed in osteosarcoma cells.    
Genetic compensation consecutive to gene inacti-
vation is an effect that has previously been de-
scribed in animals and plants such as Arabidopsis 
(29). Accordingly, compensation by induction of 
paralogous genes often occurs in parallel to lethal 
mutations (37). Our results on the induction of 
GLT25D2 in GLT25D1-null cells are in agree-
ment with such a compensatory reaction and un-
derline the necessity to inactivate both collagen 
galactosyltransferase isoforms in order to obtain 
a complete loss of collagen glycosylation. Our 
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failure to isolate cell clones harboring both inac-
tive GLT25D1 and GLT25D2 genes supports the 
notion that collagen glycosylation could be essen-
tial for osteosarcoma cell viability and that the in-
duction of GLT25D2 is required to prevent the 
complete loss of collagen galactosyltransferase 
activity when the main GLT25D1 isoform is dis-
rupted.     
The inactivation of GLT25D1 led to the upregu-
lation of collagen type I expression, which is the 
main type of collagen produced in SaOS-2 cells. 
Upregulation of collagen type I in response to 
mutation of the post-translational machinery is 
also seen in fibroblasts from Bruck syndrome 
type 2 patients, in which mutations in PLOD2 en-
coding the lysyl hydroxylase 2 isoform decrease 
the level of telopeptide lysyl hydroxylation and 
thereby the formation of telopeptide-based inter-
molecular crosslinks (9). By contrast, hyper-mod-
ification of collagen, as observed in osteogenesis 
imperfecta caused by delayed collagen folding, 
does not increase collagen type I production 
(38,39). The capping of Hyl by glycosylation may 
act as a signal for the packaging of folded colla-
gen into vesicular structures (40) in order to be 
transported to Golgi cisternae. Other classes of 
glycosylation, such as N-linked glycosylation, 
also convey signals for folded glycoproteins to 
depart the ER compartment (41). Carbohydrate-
binding proteins, such as ERGIC53 (42), recog-
nize glycan chains on glycoproteins and mediate 
their transfer to the cis-Golgi compartment. 
Collagen type I is regulated by various factors in-
cluding interleukins, insulin-like growth factor-1 
and transforming growth factor-β (43). Mice de-
ficient for β1-integrin lack feedback regulation of 
collagen synthesis (44). Since glycosylation was 
shown to impact collagen-integrin interaction, in-
tegrins may be involved in the collagen type I up-
regulation seen in GLT25D1-null cells by modu-
lated binding of collagen to integrin and subse-
quent alteration of transforming growth factor-β 
signaling. Another collagen interacting receptor, 
uPARAP, also depends on collagen glycosylation 
for matrix remodeling. uPARAP mediates the 
preferential endocytosis of glycosylated collagen 
IV and V (19,45). uPARAP itself has no direct 
regulatory function in collagen expression since 
uPARAP-/- mice show normal collagen produc-
tion. Nevertheless, uPARAP could be regulating 
collagen homeostasis by altered collagen uptake, 
thereby changing the intracellular collagen pool 
and making it available for intracellular feedback 
regulation.  
Collagen glycosylation is conserved in the animal 
kingdom from sponges to humans (14-17), sug-
gesting an important contribution of glycosyla-
tion to collagen properties in the extracellular ma-
trix. In addition to the intracellular functions in-
vestigated in the present study of osteosarcoma 
cells, glycosylation may be involved in the organ-
ization of collagens in the extracellular space. 
Glycosylation has been suggested to regulate 
crosslink formation in fibrillar collagens (46). 
Also, the glycosylation of collagenous domains of 
adiponectin, serum mannose-binding lectin, and 
complement factor C1q has been involved in the 
control of subunit oligomerization (47,48). 
Whereas the present study uncovered an unex-
pected link between collagen glycosylation and 
collagen type I expression in osteosarcoma cells, 
the inactivation of GLT25D1 and GLT25D2 in 
model organisms will be required to uncover the 
role of collagen glycosylation in shaping the ex-
tracellular matrix. 
Materials and Methods 
Cell lines and culture conditions – SaOS-2 cells 
(ATCC:HTB-85), U2OS cells (ATCC:HTB-96) 
and MG63 cells (ATCC: CRL-1427) were pro-
vided by Dr. Roman Muff (Sarkomzentrum Zü-
rich, University of Zurich). All cell lines were au-
thenticated (Microsynth, Balgach, Switzerland) 
and negatively tested for mycoplasma contamina-
tion. Cells were grown in McCoy’s 5A (Modi-
fied) medium (Thermo Fisher, Waltham, MA) 
containing 15% fetal bovine serum (Biochrom, 
Berlin, Germany) at 37°C in 5% CO2. 
Cloning and transfection of CRISPR/Cas9 
vectors – The guide RNA (gRNA) sequences for 
GLT25D1 exon 2 (fw: 5’-CACCGGAAGAG-
TTTGTACCATTCCG-3’, rev: 5’- AAACCG-
GAATGGTACAAACTCTTC-3’), for GLT25D2 
exon 3 (fw: 5’-CACCGCCATGTGATGAAAC-
TACGAC-3’, rev: 5’-AAACGTCGTAGTTTC-
ATCACATGGC-3’) and for the control construct 
(fw: 5’-CACCGGAAGAGTTTGTACCTTTCC 
G-3’, rev: 5’- AAACCGGAAAGGTACAAAC-
TCTTC-3’) were ligated into the BbsI sites of 
pSpCas9(BB) (gift from Dr. Feng Zhang, 
Addgene plasmid # 48139). Osteosarcoma cells 
were transfected using the AMAXA nucleofector 
kit (Lonza, Basel, Switzerland) according to the 
manufacturer protocol. Cells were selected for 
positive transfection with 0.5 µg/ml of puromycin 
(Santa Cruz Biotechnology Inc, Dallas, TX). Sin-
gle clones were isolated and analyzed for muta-
tions in the targeted genes using the Surveyor Nu-
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clease assay (Integrated DNA Technologies, Cor-
alville, IA) (49) and the primers 5’-GGA-
GAAGTGTCCTGTCCAGGGATAC-3’, 5’-AC-
AGGGAACGGCTTGGGCAAAGGTC-3’ for 
GLT25D1 exon 2 and 5’-CCCTGATGAAATT-
GGACCAAAGC-3’, 5’-TGCCTTTCTTAAAA- 
AGTGGGGG-3’ for GLT25D2 exon 3. Muta-
tions were confirmed by Sanger sequencing (Mi-
crosynth). 
Cloning and transfection of GLT25D1 overex-
pression vector – GLT25D1 cDNA was cloned 
from the pFastBacI baculovirus transfer vector 
from (18) in pcDNA3.1(+) (Thermo Fisher) using 
the NotI and XbaI restriction sites. SaOS-2 cells 
were transfected using AMAXA nucleofector kit 
(Lonza). Cells were selected 48 h after positive 
transfection using 2.5 µg/ml of geneticin (Thermo 
Fisher) for 10 days.  
Collagen galactosyltransferase assay – 107 cells 
were lysed in 200 µl of Tris-buffered saline, 1% 
Triton X-100, pH 7.4 for 15 min on ice. Nuclei 
and debris were removed by spinning at 13’000 x 
g for 10 min at 4°C and supernatants were used as 
enzyme source. Bovine collagen type I was heat-
denatured for 10 min at 60°C and kept on ice until 
use. Activity assays included 10 µl of cell lysate, 
0.5 mg/ml denatured collagen acceptor, 60 µM 
UDP-Gal, 50’000 cpm of UDP-[14C]Gal (GE 
Healthcare, Little Chalfont, UK), 10 mM MnCl2, 
20 mM NaCl, 50 mM morpholinepropanesulfonic 
acid (pH 7.4) and 1 mM 1,4-dithiothreitol. Reac-
tions were incubated for 3 h at 37°C and stopped 
by addition of 500 µl of 5% trichloroacetic acid 
5% phosphotungstic acid for 30 min on ice. Pre-
cipitated proteins were recovered on filters using 
a vacuum manifold, washed with 15 ml 50% eth-
anol and radioactivity was measured in a Tri-Carb 
2900TR scintillation counter (PerkinElmer Life 
Sciences).  
Quantitative PCR analysis – Total RNA was ex-
tracted from 5x106 cells using TRIzol reagent 
(Life Technologies, Carlsbad, CA) according to 
the manufacturer protocol. First strand cDNA was 
produced using 2 µg of total RNA and RevertAid 
reverse transcriptase (Life Technologies). 10 µl 
of 2x SsoAdvanced universal SYBR Green Su-
permix (Bio-Rad) were mixed with 1 µl of trans-
lated cDNA and 1 µl of 10 µM diluted primer pair 
(table I) in a 20 µl reaction. Specific real-time 
PCR primers (Table 1) for the unfolded protein 
response were selected from Oslowski et al. (50). 
Primers for collagen type I COL1A1 and collagen 
type V COL5A1 mRNA quantification were de-
signed using the primer-BLAST software (51) 
and encompassed exon sequences flanking at 
least one intron.  
Collagen extraction – Osteosarcoma cells were 
grown to 70% confluency in DMEM containing 
2% fetal calf serum, 50 µg/ml ascorbate and 50 
µg/ml catalase. Ascorbate and catalase were re-
plenished every 48 h for 8 days. Medium and cells 
were collected and digested at 10 µg/ml pepsin in 
1 M HCl for 6 h at 22°C. Neutral pH was restored 
by addition of 1 M NaOH and collagens were pre-
cipitated in 50% ethanol at -20°C overnight. Col-
lagens were resuspended in 10 ml 0.1 M acetic 
acid at 4°C for 48 h, then concentrated and puri-
fied using 100 kDa-cutoff Amicon ultra centrifu-
gal filter units (Sigma-Aldrich). Collagens were 
diluted to 0.1 mg/ml and stored at 4°C for 72 h 
prior to analysis.  
HPLC amino acid analysis – Purified collagens 
(10 μg) were hydrolyzed in 500 μl of 4 M KOH 
at 105°C for 20 h. Hydrolysates were neutralized 
using perchloric acid. Salt precipitates were re-
moved and supernatant dried down under nitro-
gen, washed twice with 500 μl of water, then 
dried down again. Samples were resuspended in 
100 μl of water and derivatized using 9-fluorenyl-
methoxycarbonyl chloride following the proce-
dure of Bank et al. (52). Derivatized amino acid 
samples were analyzed by reverse phase HPLC 
(18). 
Circular dichroism – Purified collagens were di-
luted to 0.1 mg/ml in 0.1 M acetic acid. Ellipticity 
was measured between 210 and 250 nm in a spec-
tropolarimeter (J-810, Jasco) with a thermostated 
quartz cuvette with 1 mm length. Thermal stabil-
ity was analyzed at 222 nm under heating at a rate 
of 0.5°C/min from 30 to 50°C. For refolding, col-
lagen (1 mg/ml) in PBS was denatured for 5 min 
at 50°C and ellipticity was monitored at 222 nm 
for 20 h. 
Immunofluorescence – Cells were grown on 
sterile 11 mm glass coverslips for 48 h, then fixed 
in 4% paraformaldehyde in phosphate-buffered 
saline (PBS) for 15 min at room temperature, then 
permeabilized with 0.5% saponin for 10 min at 
room temperature. Cells were incubated with 5% 
bovine serum albumin (Sigma-Aldrich) for 1 h, 
then with primary antibodies diluted in PBS, 
0.05% Tween, 1% bovine serum albumin for 1 h. 
After three wash steps in PBS, 0.05% Tween, 
cells were incubated with secondary antibodies 
 at U
ZH
 H
auptbibliothek / Zentralbibliothek Zuerich on January 6, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Accumulation of collagen caused by depleted glycosylation 
7 
 
for 1 h at room temperature. Cells were washed 
three times in PBS and nuclei were stained with 
DAPI (Biotium, Hayward, CA). Coverslips were 
mounted on ProLong Gold antifade medium (Life 
Technologies). Antibodies used were mouse anti-
collagen type I (ab6308, Abcam, Cambridge, 
UK), rabbit anti-collagen type I (ab34710, 
Abcam), goat anti-collagen type III (ab24129, 
Abcam), rabbit anti-collagen type V (ab7046, 
Abcam), rabbit anti-GLT25D1 (ab151011, 
Abcam), mouse anti-PDI(RL90) (Alexis 804-
012, Enzo Life Sciences, Lausen, Switzerland) 
and rabbit anti-giantin (ab24586, Abcam). The 
secondary antibodies used were goat anti-mouse 
647 (ab150119, Abcam), goat anti-rabbit 488 
(ab150077, Abcam) and donkey anti-goat 488 
(ab150129, Abcam). 
Image Acquisition and channel intensity quan-
tification – Coverslips were imaged using a con-
focal laser scanning microscope type Leica TCS 
SP8 using a HCX PL APO CS2 oil objective lens 
at 63x magnification, f1.4 numerical aperture at 
room temperature. The fluorophores DAPI, Alexa 
488 and Alexa 647 were excited sequentially at 
405, 488 and 638 nm, respectively. The spectral 
emission detection unit was set between 415 nm 
and 525 nm for DAPI, between 495 nm and 590 
nm for Alexa 488 and between 645 nm and 750 
nm for Alexa 647. Images were recorded at a res-
olution of 1400 x 1400 pixels at 1000 Hz, line av-
erage = 3 and z-stacks (~25) height was set to sys-
tem optimized by the software. Images were rec-
orded using two hybrid detectors using the Leica 
LAS X software (Leica Microsystems AG, Heer-
brugg, Switzerland). 3D images were projected to 
2D using Imaris 7 (Bitplane AG, Switzerland) 
with the according MATLAB plugin (Math-
Works, Bern, Switzerland) using MIP projection 
on x-y plane.  Channel intensities were quantified 
using ImageJ 1.50B (53) as described (54). 
Western Blot analysis – 5x106 cells were lysed 
in RIPA lysis buffer for 30 min on ice, then spun 
for 15 min at 13000 x g at 4°C. Amounts of 20 µg 
of whole protein lysates were resolved on 10% 
SDS-PAGE. Proteins were blotted on a nitrocel-
lulose membrane (GE Healthcare) and blocked in 
5% skim milk powder in PBS for 1 h. Membranes 
were incubated overnight at 4°C with anti-
GLT25D1 antibody at 1:250 (ab151011, Abcam), 
anti-collagen type I at 1:10’000 (ab138492, 
Abcam) or anti-β-tubulin I at 1:10’000 (Sigma-
Aldrich) in Tris-buffered saline, 0.05% Tween, 
1% bovine serum albumin. Secondary goat anti 
rabbit or goat anti mouse antibodies coupled to 
horseradish peroxidase at 1:10’000 (Sigma-Al-
drich) were diluted in Tris-buffered saline, 0.05% 
Tween and incubated for 1 h at room temperature.  
Pulse chase labelling of collagens – Cells were 
plated in 6-well plates at 2.5 x 105 cells per well 
and incubated for 24 h at 37°C. Medium was ex-
changed with DMEM (Sigma Aldrich) with 10% 
fetal bovine serum (Biochrom AG) containing 50 
µg/ml ascorbate and 50 µg/ml catalase and cells 
were incubated overnight at 37°C. Cells were 
washed once in PBS, then pulsed in 1 ml of 
DMEM, 50 µg/ml ascorbate, 20 µCi/ml L-
[14C(U)]-proline (Perkin Elmer, Waltham, MA) 
for 4 h. Chase was initiated by changing medium 
to DMEM, 50 µg/ml ascorbate, 30 µg/ml L-pro-
line. Secreted and cellular collagens were di-
gested in the cell medium using 25 µg/ml pepsin 
in 1 M HCl for 2 h at 4°C. Neutral pH was re-
stored by addition of 1 M NaOH and collagens 
were precipitated in 50% ethanol at -20°C over-
night, then resuspended in Laemmli buffer. Col-
lagens were separated in 9% SDS-PAGE and 
blotted on nitrocellulose membrane (GE 
Healthcare) prior to autoradiography. Band inten-
sity was quantified using the open source soft-
ware ImageJ (53) with the gel-analyzer plugin. 
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Figure Legends 
Figure 1: Characterization of GLT25D1 and GLT25D2 inactivation in osteosarcoma cell lines.  A) 
Real-time PCR analysis of GLT25D1, GLT25D2 and PLOD3 relative to GAPDH expression levels in 
SaOS-2, MG63 and U2OS cells (mean +/- SD, n=3 independent experiments). B) Representation of 
GLT25D1 and GLT25D2 gene structure. Dashes mark exons, blue dashes mark the gRNA target re-
gion, red dashes mark the glycosyltransferase coding region. C) Sequences of gRNAs targeting 
GLT25D1 and GLT25D2 and sequences of the targeted segment in cell clones transfected with control 
gRNA (C), with gRNA targeting GLT25D1 (D1a, clone 1; D1b, clone 2), and GLT25D2 (D2). D) 
Western blot of GLT25D1 in GLT25D1-null cells with and without overexpression of GLT25D1 
cDNA (rGLT25D1). One representative experiment is shown (total n=3 independent experiments). E) 
Galactosyltransferase activity in lysates of control (C), GLT25D1-null (D1a, D1b) and GLT25D2-null 
(D2) cells with and without GLT25D1 cDNA (rGLT25D1) overexpression (mean +/- SD, n=3 inde-
pendent experiments). 
 
Figure 2: Transcription analysis of collagen and collagen modifying enzymes. Real-time PCR anal-
ysis was performed on GLT25D1-null (D1a, D1b), GLT25D2-null (D2) and control (C) cell lines with 
and without GLT25D1 (rGLT25D1) overexpression. Primers specific for A) GLT25D1, B) GLT25D2, 
C) PLOD3 D) COL1A1 and E) Col5A1 were used. Statistically significant differences as determined 
by two tailed student’s t-test (p<0.05) are marked by stars (n=3 independent experiments).  
 
Figure 3: Analysis of collagen post-translational modifications and triple helical stability. A) 
Amino acid analysis of collagens extracted from control (C) and GLT25D1-null cells (D1). Collagens 
were alkaline-hydrolysed and FMOC-labelled before separation by HPLC. Hyp: hydroxyproline, GG-
Hyl: glucosylgalactosyl-hydroxylysine, Hyl: hydroxylysine. B) Zoom of region containing glycosyl-
ated Hyl. C) Circular dichroism of collagens extracted from control (C) and GLT25D1-null (D1) cell 
lines. Spectra were recorded at 10°C between 210 and 250 nm in a spectropolarimeter. D) Thermal 
transition of control (C) and GLT25D1-null (D1) collagens in 0.1 M acetic acid. Temperature was 
raised from 30°C to 50°C with 0.5°C/min. Tm value was calculated at 50% triple helical signal. One 
representative experiment is shown (total n=3 independent experiments). E) Refolding of control (C) 
and GLT25D1-null (D1) collagens in PBS. Collagens were denatured for 5 min at 50°C prior to refold-
ing at 20°C.  
 
Figure 4: Immunofluorescent analysis. A) Collagen type I and GLT25D1 staining in control (C), 
GLT25D1-null (D1a, D1b), and GLT25D2-null (D2) cells with and without overexpression of 
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GLT25D1 cDNA (+GLT25D1). White arrows mark cells expressing the transfected GLT25D1 cDNA. 
Scale bar equals 10 µm. B) Quantification of collagen type I channel intensity based on 50 cells. Stars 
above bars indicate statistically significant differences based on two-tailed paired t-test (p<0.05). C) 
Western blot of collagen type I in GLT25D1-null (D1a, D1b), GLT25D2-null (D2), control (C) and 
GLT25D1 cDNA (+rGLT25D1) overexpressing cells. One representative experiment is shown (total 
n=3 independent experiments).  
 
Figure 5: Immunofluorecent analysis of collagen type III and V and colocalization of collagen 
type I with ER and Golgi. A) Immunofluorescent staining of control (C) and GLT25D1-null (D1) 
cells with anti-collagen type V and anti-collagen type III antibodies (red). B) Colocalization of colla-
gen type I (red) and the ER marker PDI (green). C) Colocalization of collagen type I (red) and the 
Golgi marker giantin (green). White arrows point to Golgi and collagen type I positive region. 
 
Figure 6: Analysis of the unfolded protein response. A-D) Real-time PCR analysis of RNA ex-
tracted from control (C) and GLT25D1-null (D1) cells. Specific primers for A) XBP1, B) spliced 
XPB1, C) GRP78 and D) ATF4 were used with or without induction of the unfolded protein response 
using tunicamycin (TMC). Statistically significant differences as determined by two tailed student’s t-
test (p<0.05) are marked by stars (n=3 independent experiments). 
 
Figure 7: Analysis of collagen secretion. A-D) Pulse chase analysis of collagens from control (C) (A) 
and GLT25D1-null (D1) (B) cells after pulse period of 4h. Collagen bands were quantified for cellular 
collagen (C) and for secreted collagens (D) using imageJ. One representative experiment is shown (to-
tal n=3 independent experiments). 
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Table I. Primer pairs used for amplification in real-time PCR reactions. 
Gene  Forward primer Reverse Primer 
COL1A1 5’-GCTCGTGGAAATGATGGTGC-3’ 5’-ACCCTGGGGACCTTCAGAG-3’ 
COL5A1 5’-CTTGGCCCAAAGAAAACCCG-3’ 5’-TAGGAGAGCAGTTTCCCACG-3’ 
GAPDH 5’-CGCTCTCTGCTCCTCCTGTT-3’ 5’-CCATGGTGTCTGAGCGATGT-3’ 
spliced XBP1 5’-TGCTGAGTCCGCAGCAGGTG-3’ 5’-ATCCATGGGGAGATGTTCTGG-3’ 
unspliced XBP1 5’-CAGCACTCAGACTACGTGCA-3’ 5’-TGGCCGGGTCTGCTGAGTCCG-3’ 
ATF4 5’-GTTCTCCAGCGACAAGGCTA-3 5’-ATCCTCCTTGCTGTTGTTGG-3’ 
GRP78 
5’-TGTTCAACCAATTATCAG-
CAAACTC-3’ 
5’-TTCTGCTGTATCCTCTTCACCAGT-3’ 
GLT25D1 5’-ACTCACGCTACGAGCATGTC-3’ 5’-GTGTCAGGGTTGAGGATCAG-3’ 
GLT25D2  5’-ACTATGGCTACCTGCCCATC-3’ 5’-GGGACAACTGAGACATACTG-3’ 
PLOD3 5’-AGAACCTCAACGGGGCTTTA-3’ 5’-CTTAGTGGGACCGTTTCCAT-3’ 
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